CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of the Oncoxin-Viusid® Nutritional Supplement on the Quality of Life of Patients With Advanced or Metastatic Ovarian Epithelial Cancer. Clinical Trial Phase II.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03562897
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:35.519462+00:00
Published At: 2022-07-06T00:00:00+00:00
Record Updated At: 2022-07-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Carcinoma", "Ovarian Neoplasm", "Endocrine Gland Neoplasm", "Urogenital Neoplasms", "Ovarian Diseases", "Adnexal Diseases", "Genital Diseases, Female", "Female Urogenital Diseases", "Female Urogenital Diseases and Pregnancy Complications", "Endocrine System Diseases", "Gonadal Disorders", "Genital Neoplasm, Female", "Neoplasms, Glandular and Epithelial"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-07-06"
protocolSection.identificationModule.nctId: "NCT03562897"
protocolSection.identificationModule.officialTitle: "Efficacy of the Oncoxin-Viusid\u00ae Nutritional Supplement on the Quality of Life of Patients With Advanced or Metastatic Ovarian Epithelial Cancer. Clinical Trial Phase II."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.